Octostim (Desmopressin Acetate)

Desmopressin Acetate, the active ingredient in Octostim, is an antidiuretic hormone analog presented as a 0.1 mg oral tablet for systemic use. It helps control excessive urine production in conditions such as central diabetes insipidus and certain bleeding disorders. GNH USA supplies Octostim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Octostim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Octostim is an antidiuretic hormone analog that acts on the body's water‑balance pathways. - Central diabetes insipidus: reduces excessive thirst and urine output. - Nocturnal enuresis (bed‑wetting) in children: decreases nighttime urine production. - Mild hemophilia A or von Willebrand disease (pre‑surgical): raises plasma levels of factor VIII and von Willebrand factor to reduce bleeding risk.

Desmopressin may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity. - Nasal irritation: dryness or mild burning if administered intranasally. - Nausea or upset stomach. - Hyponatraemia: low blood sodium, usually mild. - Flushing or warmth sensation.

Serious or Rare Side Effects: - Severe hyponatraemia with seizures or coma. - Thromboembolic events such as deep‑vein thrombosis. - Allergic reactions: rash, itching, or anaphylaxis. - Cardiac arrhythmias linked to electrolyte shifts. - Acute pulmonary oedema in susceptible individuals.

Before using Octostim, consider the following safety points: - Assess renal function: impaired kidneys increase risk of fluid overload. - Monitor serum sodium: hyponatraemia can develop, especially with high fluid intake. - Review cardiovascular status: caution in patients with heart failure. - Evaluate bleeding risk: use cautiously in patients with known clotting disorders. - Store at ambient temperature: keep below 25°C, in the original container, protected from moisture.

Desmopressin can interact with several medicines that affect fluid balance or haemostasis.

Major Interactions (Avoid): - Concomitant use of carbamazepine or other enzyme‑inducing antiepileptics: reduces desmopressin effectiveness. - NSAIDs (high‑dose ibuprofen, naproxen): increase risk of hyponatraemia. - Warfarin or other anticoagulants: may alter bleeding risk when desmopressin is used for haemostatic purposes.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): amplify water‑retention effects. - Selective serotonin reuptake inhibitors (SSRIs): modestly raise hyponatraemia risk. - ACE inhibitors or ARBs: additive effect on sodium balance.